HEPATITIS C

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. The virus persists in the liver in about 75% to 85% of those initially infected. Early on chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop complications such as liver failure, liver cancer, or esophageal and gastric varices

Contact Details

IKRIS Pharma Network Pvt. Ltd.
905 , I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120–2400370.
M: + 91 8130290915
E:info@ikrispharmanetwork.com

Query Form

HEPATITIS C MEDICATIONS

Daklinza Daclatasvir

DAKLINZA is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for the treatment of chronic HCV genotype 3 infection.

More Details

Olysio Simeprevir Capsules

Olysio is Indicated for treatment of chronic hepatitis C (CHC); efficacy has been established in combination with peginterferon alfa and ribavirin in patients with HCV genotype 1 infection with compensated liver disease (including cirrhosis)

Learn More

VIEKIRA PAK

VIEKIRA PAK is a prescription medicine used with or without ribavirin to treat people with genotype 1 chronic (lasting a long time) hepatitis C virus (HCV) infection, including people who have a certain type of cirrhosis (compensated).

Learn More